chr10-54213995-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The ENST00000320301.11(PCDH15):​c.1039C>T​(p.Leu347Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00397 in 1,612,234 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 40 hom. )

Consequence

PCDH15
ENST00000320301.11 missense

Scores

5
6
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 7.14
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059919655).
BP6
Variant 10-54213995-G-A is Benign according to our data. Variant chr10-54213995-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 46434.We mark this variant Likely_benign, oryginal submissions are: {Benign=6, Likely_benign=1, Uncertain_significance=2}. Variant chr10-54213995-G-A is described in Lovd as [Benign]. Variant chr10-54213995-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 3 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PCDH15NM_033056.4 linkuse as main transcriptc.1039C>T p.Leu347Phe missense_variant 10/33 ENST00000320301.11 NP_149045.3
PCDH15NM_001384140.1 linkuse as main transcriptc.1039C>T p.Leu347Phe missense_variant 10/38 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkuse as main transcriptc.1039C>T p.Leu347Phe missense_variant 10/331 NM_033056.4 ENSP00000322604 Q96QU1-1
PCDH15ENST00000644397.2 linkuse as main transcriptc.1039C>T p.Leu347Phe missense_variant 10/38 NM_001384140.1 ENSP00000495195

Frequencies

GnomAD3 genomes
AF:
0.00315
AC:
480
AN:
152182
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00457
Gnomad OTH
AF:
0.00430
GnomAD3 exomes
AF:
0.00380
AC:
956
AN:
251374
Hom.:
11
AF XY:
0.00403
AC XY:
548
AN XY:
135854
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.0179
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00304
Gnomad FIN exome
AF:
0.000832
Gnomad NFE exome
AF:
0.00495
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00405
AC:
5913
AN:
1459934
Hom.:
40
Cov.:
30
AF XY:
0.00416
AC XY:
3019
AN XY:
726346
show subpopulations
Gnomad4 AFR exome
AF:
0.000748
Gnomad4 AMR exome
AF:
0.00197
Gnomad4 ASJ exome
AF:
0.0168
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00302
Gnomad4 FIN exome
AF:
0.00101
Gnomad4 NFE exome
AF:
0.00427
Gnomad4 OTH exome
AF:
0.00454
GnomAD4 genome
AF:
0.00316
AC:
481
AN:
152300
Hom.:
3
Cov.:
33
AF XY:
0.00302
AC XY:
225
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.000794
Gnomad4 AMR
AF:
0.00288
Gnomad4 ASJ
AF:
0.0161
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00269
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00457
Gnomad4 OTH
AF:
0.00425
Alfa
AF:
0.00486
Hom.:
8
Bravo
AF:
0.00331
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00523
AC:
45
ExAC
AF:
0.00361
AC:
438
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 22, 2016p.Leu347Phe in exon 10 of PCDH15: This variant has not been reported in the lite rature but has now been identified by our laboratory in 5/197 (2.5%) individuals with hearing loss yet none of these individuals had a second PCDH15 variant and one family had an alternate cause of hearing loss. In summary, this data sugges ts that the variant is benign. This variant is not expected to have clinical sig nificance, because it has been identified in 355/66702 European chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1 11033436). -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 11, 2022Variant summary: PCDH15 c.1039C>T (p.Leu347Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0038 in 251374 control chromosomes, predominantly at a frequency of 0.005 within the Non-Finnish European subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.6 fold of the estimated maximal expected allele frequency for a pathogenic variant in PCDH15 causing Usher Syndrome Type 1F phenotype (0.0032), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. Although reported in the literature, to our knowledge, no penetrant association of c.1039C>T in individuals affected with Usher Syndrome Type 1F and no experimental evidence demonstrating its impact on protein function have been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments and a majority consensus as Benign (n=4) (VUS, n=2). Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 14, 2013- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 22, 2020- -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJan 10, 2019This variant is associated with the following publications: (PMID: 26969326) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2024PCDH15: BS2 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Usher syndrome type 1F Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Usher syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.12
T;.;.;.;.;T;.;.;T;.;T;.;.;T;.;T;.;.;.;.;.;.;T;.
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.0060
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.32
T
MutationAssessor
Uncertain
2.6
.;.;.;.;M;.;.;.;.;.;.;M;.;.;.;.;.;.;.;.;.;.;M;M
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-2.9
D;.;.;.;.;.;D;D;.;D;.;D;D;.;D;.;.;D;D;D;.;D;D;D
REVEL
Benign
0.25
Sift
Uncertain
0.0020
D;.;.;.;.;.;D;D;.;D;.;D;D;.;D;.;.;D;T;D;.;D;D;D
Sift4G
Pathogenic
0.0
D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0, 1.0, 1.0, 1.0
.;.;.;.;.;.;.;.;.;.;.;.;D;.;D;.;.;D;D;D;.;D;D;D
Vest4
0.81
MVP
0.71
MPC
0.21
ClinPred
0.010
T
GERP RS
5.0
Varity_R
0.50
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111033436; hg19: chr10-55973755; COSMIC: COSV105882550; API